Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Targeted Therapy-Reference-Cited by-同舟云学术

Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Targeted Therapy

Published:2018-07-01 Issue:19 Volume:36 Page:2006-2006
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Copur Mehmet Sitki¹,Crockett David¹,Gauchan Dron¹,Ramaekers Ryan¹,Mleczko Kris¹

Affiliation:

1. Mehmet Sitki Copur, David Crockett, Dron Gauchan, and Ryan Ramaekers, CHI Health St Francis Cancer Treatment Center, Grand Island, NE; and Kris Mleczko, CHI Health St Francis Medical Center, Grand Island, NE

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2018.78.8240

Reference7 articles.

1. Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice Guideline Update

2. Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

3. Anaplastic lymphoma kinase (ALK) gene rearrangement in non-small cell lung cancer (NSCLC): Results of a multi-centre ALK-testing

4. Next-generation sequencing facilitates detection of the classic E13-A20 EML4-ALK fusion in an ALK-FISH/IHC inconclusive biopsy of a stage IV lung cancer patient: a case report

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GNPNAT1 Serves as a Prognostic Biomarker Correlated with Immune Infiltration and Promotes Cancer Cell Metastasis through Stabilization of Snai2 in Lung Adenocarcinoma;Biomedicines;2024-07-04

2. Future of Nanotechnology-Based Drug Discovery;Nanotechnology in Drug Discovery;2024-07-04

3. GNPNAT1 promotes cancer cells metastasis through stabilization Slug in lung adenocarcinoma;2024-04-22

4. Phosphatidylserine-Specific Phospholipase A1 Limits Aggressiveness of Lung Adenocarcinoma by Lysophosphatidylserine and Protein Kinase A–Dependent Pathway;The American Journal of Pathology;2022-06

5. Emerging Nanotherapeutic Approaches to Overcome Drug Resistance in Cancers with Update on Clinical Trials;Pharmaceutics;2022-04-15